Moderna's mRNA-based pandemic flu vaccine – which had federal funding pulled earlier this year amid an increasingly vaccine-sceptic stance by the Trump administration – has been thrown a lifeline by ...

Activist investor Shah Capital has called on the board of directors at Novavax to put the company up for sale, citing a "litany of missteps" at the company. Chief among its criticisms is Novavax's ...